Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ferguson GT"'
Autor:
Martinez FJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA. Electronic address: fjm2003@med.cornell.edu., Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, UK., Trivedi R; AstraZeneca, Durham, NC, USA., Jenkins M; AstraZeneca, Cambridge, UK., Darken P; AstraZeneca, Gaithersburg, MD, USA., Aurivillius M; AstraZeneca, Gothenburg, Sweden., Dorinsky P; AstraZeneca, Durham, NC, USA.
Publikováno v:
Respiratory medicine [Respir Med] 2021 Aug-Sep; Vol. 185, pp. 106509. Date of Electronic Publication: 2021 Jun 18.
Autor:
Martinez FJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, New York., Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, Michigan., Wedzicha JA; National Heart and Lung Institute, London, United Kingdom., Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester, United Kingdom., Wang C; National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China., Rossman K; AstraZeneca, Morristown, New Jersey., St Rose E; AstraZeneca, Morristown, New Jersey., Trivedi R; AstraZeneca, Durham, North Carolina., Ballal S; AstraZeneca, Morristown, New Jersey., Darken P; AstraZeneca, Wilmington, Delaware; and., Aurivillius M; AstraZeneca, Gothenburg, Sweden., Reisner C; AstraZeneca, Morristown, New Jersey., Dorinsky P; AstraZeneca, Durham, North Carolina.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Mar 01; Vol. 203 (5), pp. 553-564.
Autor:
Rabe KF; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Martinez FJ; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Ferguson GT; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Wang C; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Singh D; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Wedzicha JA; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Trivedi R; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., St Rose E; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Ballal S; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., McLaren J; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Darken P; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Aurivillius M; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Reisner C; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.)., Dorinsky P; From LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany (K.F.R.); the Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York (F.J.M.); the Pulmonary Research Institute of Southeast Michigan, Farmington Hills (G.T.F.); the National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing (C.W.); the Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester (D.S.), and the National Heart and Lung Institute, Imperial College London, London (J.A.W.) - both in the United Kingdom; AstraZeneca, Durham, NC (R.T., P. Dorinsky); AstraZeneca, Morristown, NJ (E.S.R., S.B., P. Darken, C.R.); AstraZeneca, Gaithersburg, MD (J.M.); and AstraZeneca, Gothenburg, Sweden (M.A.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2020 Jul 02; Vol. 383 (1), pp. 35-48. Date of Electronic Publication: 2020 Jun 24.
Autor:
Ichinose M; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Fukushima Y; Department of Internal Medicine, Fukuwa Clinic, Tokyo, Japan., Inoue Y; Clinical Research Center, National Hospital Organization, Kinki-Chuo Chest Medical Center, Osaka, Japan., Hataji O; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Großhansdorf, Germany., Hayashi N; AstraZeneca K.K., Osaka, Japan., Okada H; AstraZeneca K.K., Osaka, Japan., Takikawa M; AstraZeneca K.K., Osaka, Japan., Bourne E; AstraZeneca, Durham, NC, USA., Ballal S; AstraZeneca, Morristown, NJ, USA., DeAngelis K; Formerly of AstraZeneca, Durham, NC, USA., Aurivillius M; AstraZeneca, Gothenburg, Sweden., Reisner C; AstraZeneca, Morristown, NJ, USA., Dorinsky P; AstraZeneca, Durham, NC, USA.
Publikováno v:
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2019 Dec 23; Vol. 14, pp. 2993-3002. Date of Electronic Publication: 2019 Dec 23 (Print Publication: 2019).
Autor:
Ichinose M; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Fukushima Y; Department of Internal Medicine, Fukuwa Clinic, Tokyo, Japan., Inoue Y; Clinical Research Center, National Hospital Organization, Kinki-Chuo Chest Medical Center, Osaka, Japan., Hataji O; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany., Hayashi N; AstraZeneca K.K., Osaka, Japan., Okada H; AstraZeneca K.K., Osaka, Japan., Takikawa M; AstraZeneca K.K., Osaka, Japan., Bourne E; AstraZeneca, Durham, NC, USA., Ballal S; AstraZeneca, Morristown, NJ, USA., DeAngelis K; Formerly of AstraZeneca, Durham, NC, USA., Aurivillius M; AstraZeneca, Gothenburg, Sweden., Dorinsky P; AstraZeneca, Durham, NC, USA., Reisner C; AstraZeneca, Morristown, NJ, USA.
Publikováno v:
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2019 Dec 23; Vol. 14, pp. 2979-2991. Date of Electronic Publication: 2019 Dec 23 (Print Publication: 2019).
Autor:
Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany. Electronic address: k.f.rabe@lungenclinic.de., Martinez FJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Wang C; National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China., Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester, UK., Wedzicha JA; Respiratory Division, National Heart and Lung Institute, London, UK., Trivedi R; AstraZeneca, Durham, NC, USA., St Rose E; AstraZeneca, Morristown, NJ, USA., Ballal S; AstraZeneca, Morristown, NJ, USA., McLaren J; AstraZeneca, Gaithersburg, MD, USA., Darken P; AstraZeneca, Morristown, NJ, USA., Reisner C; AstraZeneca, Morristown, NJ, USA., Dorinsky P; AstraZeneca, Durham, NC, USA.
Publikováno v:
Respiratory medicine [Respir Med] 2019 Oct - Nov; Vol. 158, pp. 59-66. Date of Electronic Publication: 2019 Aug 22.
Autor:
Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA. Electronic address: garytferguson@msn.com., Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Germany., Martinez FJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Fabbri LM; Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Medicine, University Hospital, Ferrara, Italy., Wang C; National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China., Ichinose M; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Bourne E; Pearl-a member of the AstraZeneca Group, Durham, NC, USA., Ballal S; Pearl-a member of the AstraZeneca Group, Morristown, NJ, USA., Darken P; Pearl-a member of the AstraZeneca Group, Morristown, NJ, USA., DeAngelis K; Pearl-a member of the AstraZeneca Group, Durham, NC, USA., Aurivillius M; AstraZeneca Gothenburg, Mölndal, Sweden., Dorinsky P; Pearl-a member of the AstraZeneca Group, Durham, NC, USA., Reisner C; Pearl-a member of the AstraZeneca Group, Morristown, NJ, USA; AstraZeneca, Gaithersburg, MD, USA.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2018 Oct; Vol. 6 (10), pp. 747-758. Date of Electronic Publication: 2018 Sep 16.
Autor:
Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Papi A; Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy., Anzueto A; Pulmonary Medicine and Critical Care, University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, TX, USA., Kerwin EM; Clinical Research Institute of Southern Oregon, Medford, OR, USA., Cappelletti C; Pearl - a member of the AstraZeneca Group, Durham, NC, USA., Duncan EA; Pearl - a member of the AstraZeneca Group, Durham, NC, USA., Nyberg J; Pearl - a member of the AstraZeneca Group, Morristown, NJ, USA., Dorinsky P; Pearl - a member of the AstraZeneca Group, Durham, NC, USA.
Publikováno v:
The European respiratory journal [Eur Respir J] 2018 Sep 16; Vol. 52 (3). Date of Electronic Publication: 2018 Sep 16 (Print Publication: 2018).